Patents Represented by Law Firm Cushman Darby and Cushman, IP Group of Pillsbury Madison & Sutro
-
Patent number: 6197506Abstract: The present invention provides methods and apparatus for sequencing, fingerprinting and mapping biological macromolecules, typically biological polymers. The methods make use of a plurality of sequence specific recognition reagents which can also be used for classification of biological samples, and to characterize their sources.Type: GrantFiled: April 8, 1998Date of Patent: March 6, 2001Assignee: Affymetrix, Inc.Inventors: Stephen P. A. Fodor, Dennis W. Solas, William J. Dower
-
Patent number: 6153607Abstract: A preservative-free composition containing an effective amount of a corticosteroid in an aqueous carrier to treat a dry eye condition. The composition may be provided as a part of a therapeutic regimen to treat a variety of dry eye conditions and ocular surface disorders manifesting delayed tear clearance previously not readily treatable. The composition may be packaged as containers of single dosage amounts of the corticosteroid-aqueous composition sufficient for pulsed-therapy of acute exacerbations of the irritation symptoms and ocular surface disease of conditions associated with dry eye and delayed tear clearance.Type: GrantFiled: December 4, 1996Date of Patent: November 28, 2000Assignee: University of MiamiInventors: Stephen C. Pflugfelder, Scheffer C. G. Tseng, Andrew J. W. Huang
-
Patent number: 6136567Abstract: Plasmids which comprise: (1) an origin of replication; (2) an additional sequence required for plasmid replication or preferably a gene giving a selective advantage; and (3) two expression cassettes each of which are located between (1) and (2) but are separated by (1) and (2) from each other; and which are free from inverted repeat sequences (other than in (3)) are highly persistent though successive generations of microbes containing them.Type: GrantFiled: August 21, 1998Date of Patent: October 24, 2000Assignee: Zeneca LimitedInventors: Matthew Guy Duchars, Andrew William Topping
-
Patent number: 6126165Abstract: A hit expectation sound is emitted from a speaker in accordance with the kind of prize line on which a predetermined, prizewinning combination of symbols is expected to be arranged. The emitted hit expectation sound is transmitted to a player via sound transmitting holes provided in a lower portion of the machine. Based on the hit expectation sound being heard, the player can recognize on which of a plurality of prize lines the predetermined combination of symbols is expected to be arranged. The player can enjoy his favorite hit expectation sound by causing part of the predetermined combination of symbols to be stopped on the prize line that is associated with his favorite hit expectation sound.Type: GrantFiled: November 10, 1998Date of Patent: October 3, 2000Assignee: Aruze CorporationInventor: Yoshikazu Sakamoto
-
Patent number: 6128015Abstract: Full-motion video data with a sub-picture and sound is recorded in a DVD-ROM drive. The DVD-ROM drive is connected to an ATAPI interface. Using a data buffer of the ATAPI interface, an MPEG stream is transferred to an MPEG2 decoder on the system board at a variable rate, and video data, audio data, and a sub-picture included in the MPEG stream are decoded by the MPEG2 decoder incorporated in the system. The decoded sub-picture is drawn in a VRAM as in normal VGA graphics. The sub-picture image drawn in the VRAM is synthesized with the video from the MPEG2 decoder by a multimedia display controller and displayed on a screen.Type: GrantFiled: June 30, 1998Date of Patent: October 3, 2000Assignee: Kabushiki Kaisha ToshibaInventor: Hiroki Zenda
-
Patent number: 6124326Abstract: The invention relates to the use of flupirtine or its salts for the production of a medicament for the prophylaxis and therapy of disorders which accompany an unphysiologically high cell death rate. Of particular importance here is the treatment of organ disorders with cell-destroying processes, such as myocardial infarct, shock kidney, shock lung, senile macular degeneration or traumas as a result of mechanical, thermal, radiation or toxic influences.Type: GrantFiled: June 11, 1997Date of Patent: September 26, 2000Assignee: ASTA Medica AktiengesellschaftInventors: Gabriele Pergande, Werner E. Muller, Neville Osborne, Heinz Ulrich
-
Patent number: 6117864Abstract: Azelastine hydrochloride is combined certain fatty acids. The stability and absorbability of the composition is enhanced.Type: GrantFiled: July 8, 1997Date of Patent: September 12, 2000Assignee: ASTA Medica AktiengesellschaftInventors: Yutaka Morita, Noritoshi Koyama, Shigemitsu Ohsawa
-
Patent number: 6114147Abstract: A method is provided for immobilizing a binding protein capable of binding to a specific compound, using recombinant DNA techniques for producing said binding protein or a functional part thereof. The binding protein is immobilized by producing it as part of a chimeric protein also comprising an anchoring part derivable from the C-terminal part of an anchoring protein, thereby ensuring that the binding protein is localized in or at the exterior of the cell wall of the host cell. Suitable anchoring proteins are yeast .alpha.-agglutinin, FLO1 (a protein associated with the flocculation phenotype in S. cerevisiae), the Major Cell Wall Protein of lower eukaryotes, and a proteinase of lactic acid bacteria. For secretion the chimeric protein can comprises a signal peptide including those of .alpha.-mating factor of yeast, .alpha.-agglutinin of yeast, invertase of Saccharomyces, inulinase of Kluyveromyces, .alpha.-amylase of Bacillus, and proteinase of lactic acid bacteria.Type: GrantFiled: November 17, 1997Date of Patent: September 5, 2000Assignee: Unilever Patent HoldingsInventors: Leon Gerardus J. Frenken, Pieter de Geus, Franciscus Maria Klis, Holger York Toschka, Cornelis Theodorus Verrips
-
Patent number: 6109993Abstract: A substantially rectangle shaped frame for holding a flat-shaped electrode unit 7 is fixed to a rear panel 2 at four intermediate parts of the frame and is elastically held by a resilient retaining member 55a- - - 55d and 56a- - - -56d at four corners of the frame. Thereby, an engagement between the rear panel 2 and the flat-shaped electrode unit 7 via the frame is stably retained regardless of difference in degrees of deformations thereamong.Type: GrantFiled: September 20, 1995Date of Patent: August 29, 2000Assignee: Matsushita Electric Industrial Co., Ltd.Inventors: Hiroshi Aono, Mitsunori Yokomakura, Mitsunori Katano, Michiaki Watanabe
-
Patent number: 6107223Abstract: A method for preparing high strength and high thermal shock-resistant china for ceramic whiteware which comprises the steps of molding a china-forming raw material which mainly comprises a natural ore material capable of forming corundum through firing or a material obtained by calcining the natural ore material to form corundum, a natural ore material capable of forming mullite through firing or a material obtained by calcining the natural ore material to form mullite, a clayey material and a flux such as feldspar, nepheline or dolomite; and then firing the molded china-forming raw material. The method permits the production of cheaper china for ceramic whiteware having high strength and excellent thermal shock resistance as compared with those prepared by the conventional techniques.Type: GrantFiled: March 28, 1997Date of Patent: August 22, 2000Assignee: Toto LtdInventors: Naoki Koga, Masaki Taneo, Toshiya Nishikawa, Akio Matsumoto
-
Patent number: 6103303Abstract: Dendrite or asteroidal titanium dioxide micro-particles having a length of 0.2 to 0.5 .mu.m, a thickness of 0.05 to 0.1 .mu.m, and a specific surface area of 20 to 130 m.sup.2 /gram, are produced by treating hydrated titanium oxide particles with an alkali, mixing instantaneously the resulting reaction product with an amount of hydrochloric acid in a ratio of 1 to 4 mols of hydrochloric acid to one mol of the titanium oxide in the reaction product to effect a reaction, then aging under heat at 85.degree. C. or higher, and then drying or, if necessary, firing after the drying, and subsequently may be coated with at least one from oxides and hydrated oxides of elements selected from aluminum, silicon, titanium, zirconium, tin and antimony to improve the dispersibility and resistance to light of the particles, or may be coated with tin oxide containing antimony or indium oxide containing tin to make the particles electroconductive.Type: GrantFiled: May 25, 1995Date of Patent: August 15, 2000Assignee: Ishihara Sangyo Kaisha, Ltd.Inventors: Hideo Takahashi, Akihito Sakai, Masakazu Hattori
-
Patent number: 6093704Abstract: The side effect of decrease in body weight caused by the alkylphosphocholines such as miltefosine can be antagonized by certain acetylcholine receptor antagonists such as domperidone and pimozide. The combination of alkylphosphocholine plus the antagonist does not have any effect on the anti-tumor action of the alkylphosphocholine. The combination also caused no new side effects in the animals.Type: GrantFiled: December 5, 1997Date of Patent: July 25, 2000Assignee: ASTA Medica AktiengesellschaftInventors: Bernd Nickel, Peter Hilgard, Thomas Klenner, Jurgen Engel
-
Patent number: 6090913Abstract: A process employs amidine or amidine base and a metal compound in the presence of an alcohol or water to transesterify, or saponify esters or amides. Since the process employs relatively mild conditions, it is especially suitable for the production of optically active substances and biomolecules, e.g. peptides, amino acids and nucleic acids which are sensitive to elevated temperatures, extreme pH values and/or long reaction times since these compounds are easily racemised or denatured. The conditions additionally find use in solid phase systems. When amino acid or peptide esters are saponified, the splitting is brought about with lithium hydroxide alone under mild conditions. The use of an amidine base, more particularly DBU or DBN, in combination with the metal salt additionally accelerates the reaction so strongly that even sensitive acid derivatives can be reacted under mild conditions.Type: GrantFiled: March 27, 1997Date of Patent: July 18, 2000Assignee: Degussa-Huls AktiengesellschaftInventors: Karlheinz Drauz, Thomas Muller, Matthias Kottenhahn, Dieter Seebach, Adrian Thaler
-
Patent number: 6090047Abstract: A novel method for estimating the end-systolic pressure-volume relationship (ESPVR) is presented. The method provides for accurate estimation of the ESPVR from a single beat of the cardiac cycle. The method is based on normalized human time varying elastance curves [E.sub.N (t.sub.N)]. The ESPVR is estimated from one beat using PV data measured at normalized time t.sub.N and end-systole (t.sub.max) to predict intercept: ##EQU1## and slope: E.sub.max(SB) =P(t.sub.max)/[V(t.sub.max)-V.sub.0(SB) ]. The present invention provides a method for ESPVR estimation which is non-invasive and particularly applicable for bedside applications.Type: GrantFiled: November 3, 1997Date of Patent: July 18, 2000Assignee: Johns Hopkins University, School of MedicineInventors: David A. Kass, Hideaki Senzaki, Chen-Huan Chen
-
Patent number: 6084106Abstract: The invention relates to a new class of alkoxy silane compounds of the following general formula: ##STR1## wherein R is aliphatic or aromatic having from 1 to about 15 carbon atoms and R'comprises a hydrolyzable alkoxy functionality. These compounds are particularly useful as adhesion promoters when used with adhesives such as, for example, phenylethynyl terminated polyimide or polysulfide adhesives. The invention also relates to a method of synthesizing the alkoxy silane compounds defined above.Type: GrantFiled: April 18, 1996Date of Patent: July 4, 2000Assignee: Thiokol CorporationInventors: Russell A. Crook, Robert B. Wardle
-
Patent number: 6083979Abstract: Method of blocking aberrant Ras signaling in a mammal while avoiding excessive cell toxicity by administration of lovastatin and geranylgeraniol.Type: GrantFiled: October 9, 1996Date of Patent: July 4, 2000Assignee: University of PittsburghInventors: Said M. Sebti, Terence F. McGuire
-
Patent number: 6080726Abstract: A method of treating HSV-2 infection which comprises administering to a host subject to said infection an effective amount of a polynucleotide of the formula polyrI.polyr(C.sub.12 U) where n is an integer from 4 to 29. The polynucleotide is advantageously administered intranasally.Type: GrantFiled: September 11, 1992Date of Patent: June 27, 2000Assignees: University of Maryland, Johns Hopkins UniversityInventors: Paul O. P. Ts'o, Laure Aurelian
-
Patent number: 6074141Abstract: A scroll member has a scroll wall having an axial end having a transverse surface on which a groove 20 is cut along the spiral direction of the scroll wall, to which groove a seal member contacting a facing scroll member is received. The scroll wall has a radially inner portion having a width larger than the width of the remaining part of the scroll wall. At the radially inner portion, the groove is also widened. When molding the scroll member, a recess deeper than the depth of the groove to be machined is created. The groove is obtained by machining the scroll member as molded by a milling tool. The widened portion of the groove is formed by moving a milling tool along a closed trajectory, so that the recess is left un-machined.Type: GrantFiled: August 2, 1996Date of Patent: June 13, 2000Assignees: Nippondenso Co., Ltd., Kabushiki Kaisha Toyoda Jidoshokki SeisakushoInventors: Kimihiro Ishikawa, Takashi Miyakawa, Yasushi Watanabe, Tetsuhiko Fukanuma, Shinya Yamamoto
-
Patent number: 6075120Abstract: A bradykinin antagonist of the formula:(BKAn)(X)(Y)where BKAn is a bradykinin antagonist peptide; Y is a pharmacore; and X is a bridging link chemically joining the BKAn and Y components.Type: GrantFiled: May 12, 1995Date of Patent: June 13, 2000Assignee: Cortech, Inc.Inventors: John C. Cheronis, James K. Blodgett, Val Smith Goodfellow, Manoj Vinayak Marathe, Lyle W. Spruce, Eric T. Whalley
-
Patent number: 6072029Abstract: The invention relates to an analog of human .alpha..sub.1 -antitrypsin characterized in that it is all or part of the protein corresponding to human .alpha..sub.1 -antitrypsin in which, in 358 position, the amino-acid is selected from among arginine and little or non-oxidizable natural amino-acids when they are integrated into a protein.Type: GrantFiled: October 27, 1992Date of Patent: June 6, 2000Assignee: Transgene S.A.Inventors: Michael Courtney, Luc-Henri Tessier, Sophie Jallat, Jean-Pierre Lecocq